2005 Annual Meeting | Case Studies in Stroke

Date Wednesday 04/13/05

Time 07:00 PM - 10:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Case Studies Program

Director(s) Philip B. Gorelick, MD, MPH, FAAN

Topic(s) Cerebrovascular Disease and Interventional Neurology

Learning Objectives Upon completion:
Participants should be able to better understand blood pressure management in acute and chronic stroke patients; understand the role of statins in first and recurrent stroke prevention; understand the role of the various antiplatelet agents in recurrent stroke prevention; be familiar with diagnostic studies used to decide whether intravenous or IA tPA should be given and the indications for these agents; be familiar with new data on the use of carotid endarterectomy in asymptomatic carotid stenosis patients; and be able to diagnose challenging stroke patients.

CME Available No CME available

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
07:00 PM - 07:20 PM		Case 1: Diagnostic Tests That Help You Decide Acute Ischemic Stroke Management in Mrs. Jones Louis R. Caplan, MD, FAAN
07:00 PM - 10:00 PM		Refreshments
07:20 PM - 07:40 PM		Case 2: Should I Be Administering IV or IA tPA? Louis R. Caplan, MD, FAAN
07:40 PM - 08:00 PM		Case 3: Six Key Questions About Blood Pressure Lowering In Acute or Chronic Stroke Management Philip B. Gorelick, MD, MPH, FAAN
08:00 PM - 08:10 PM		Break
08:10 PM - 08:30 PM		Case 4: Which Antiplatelet Agent and Why for Recurrent Stroke Prevention and Are Statin Agents Indicated? Philip B. Gorelick, MD, MPH, FAAN
08:30 PM - 08:50 PM		Case 5: Rule Out CNS Vasculitis: Overrated or Or the Real McCoy? Louis R. Caplan, MD, FAAN
08:50 PM - 09:00 PM		Break
09:00 PM - 09:20 PM		Case 6: White Matter Disease and Its Variations In Practice: What Does It All Mean and What Should We Be Doing About It? Philip B. Gorelick, MD, MPH, FAAN
09:20 PM - 09:40 PM		Case 7: Carotid Endarterectomy in Asymptomatic Carotid Stenosis: YES/NO
09:40 PM - 10:00 PM		Audience Presentation of Challenging Cases and Questions

Faculty Disclosures
Philip B. Gorelick, MD, MPH, FAAN	Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. Dr. Gorelick has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Thorek Memorial Hospital. Dr. Gorelick has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Thorek Memorial Hospital.
Louis R. Caplan, MD, FAAN	No disclosure on file

��ɫ��

��ɫ��